These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8537274)

  • 21. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K; Pant ND; Neupane B; Belbase A; Baidhya R; Shrestha RK; Lekhak B; Bhatta DR; Jha B
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):62. PubMed ID: 28927454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.
    Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E
    J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
    Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum].
    Cavallo JD; Fabre R; Crenn Y; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
    Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
    Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression.
    Cai W; Fu Y; Zhang W; Chen X; Zhao J; Song W; Li Y; Huang Y; Wu Z; Sun R; Dong C; Zhang F
    BMC Microbiol; 2016 Aug; 16(1):181. PubMed ID: 27502110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae.
    Rice LB; Carias LL; Shlaes DM
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2663-4. PubMed ID: 7872765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between β-lactamase production and resistance phenotype in Klebsiella pneumoniae strains.
    Kim J; Ding T; Ahn J
    FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28591808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some enterobacteriaceae producing extended-spectrum beta-lactamases.
    Ferrara A; Dos Santos C; Cimbro M
    Chemotherapy; 1998; 44(5):313-7. PubMed ID: 9732145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.
    Rice LB; Yao JD; Klimm K; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1243-4. PubMed ID: 1929273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
    Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
    J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Gentry CA; Williams RJ
    Microb Drug Resist; 2015 Dec; 21(6):590-9. PubMed ID: 26207392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].
    Bedenić B; Boras A
    Lijec Vjesn; 2001; 123(11-12):293-6. PubMed ID: 11930754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Yagi T; Wachino J; Kurokawa H; Suzuki S; Yamane K; Doi Y; Shibata N; Kato H; Shibayama K; Arakawa Y
    J Clin Microbiol; 2005 Jun; 43(6):2551-8. PubMed ID: 15956362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae.
    Lin RD; Chin YP; Lee MH
    Phytother Res; 2005 Jul; 19(7):612-7. PubMed ID: 16161024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.
    Dehshiri M; Khoramrooz SS; Zoladl M; Khosravani SA; Parhizgari N; Motazedian MH; Jahedi S; Sharifi A
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):4. PubMed ID: 29433582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.